- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02286739
Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During TKA
4. april 2017 opdateret af: Orthosensor, Inc.
Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During Total Knee Arthroplasty
The objectives of the study are twofold: 1) Evaluate how intra-operative sensing may assist the surgeon with tibiofemoral rotational alignment by testing the precision and variability of setting tray rotation to the mid-third of the tibial tubercle.
2) Understand if patients with a combined axial rotation couple at the tibiofemoral joint and quantitative intercompartmental balance, achieved with the use of VERASENSE, exhibit less post-operative knee pain and improved clinical outcomes.
Radiographic outcomes will also be assessed to measure post-operative alignment and to evaluate the prevalence and location of radiolucency and/or osteolysis.
Studieoversigt
Status
Ukendt
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Hypothesis: TKA with VERASENSE results in a more reliable and precise option for establishing implant-to-implant congruency and joint balance leading to less knee pain, faster return to normal activities and higher patient satisfaction compared to TKA without VERASENSE.
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
500
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Florida
-
Weston, Florida, Forenede Stater
- Rekruttering
- The Cleveland Clinic Foundation
-
Kontakt:
- Cecilia Calvo
- E-mail: CALVOC@ccf.org
-
Ledende efterforsker:
- Preetesh Patel, MD
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30329
- Rekruttering
- Emory University
-
Kontakt:
- Jared O'Neal
- E-mail: jwoneal@emory.edu
-
Ledende efterforsker:
- Thomas Bradbury, MD
-
-
Illinois
-
Morton Grove, Illinois, Forenede Stater, 60053
- Rekruttering
- Illinois Bone & Joint Institute
-
Kontakt:
- Nancy R Cipparrone
- E-mail: ncipparrone@ibji.com
-
Ledende efterforsker:
- Alexander Gordon, MD
-
-
New York
-
New York, New York, Forenede Stater, 10003
- Rekruttering
- NYU Hospital for Joint Diseases
-
Kontakt:
- Ariel Aponte, CCRC
- E-mail: ariel.aponte@nyumc.org
-
Ledende efterforsker:
- Ivan Fernandez-Madrid, MD
-
-
Ohio
-
Cleveland, Ohio, Forenede Stater, 44195
- Rekruttering
- The Cleveland Clinic Foundation
-
Kontakt:
- Gannon Curtis, MD
- E-mail: curtisg@ccf.org
-
Ledende efterforsker:
- Wael Barsoum, MD
-
-
Virginia
-
Richmond, Virginia, Forenede Stater
- Rekruttering
- Virginia Commonwealth University
-
Kontakt:
- Megan Hansen
- E-mail: mhansen@mcvh-vcu.edu
-
Ledende efterforsker:
- Gregory Golladay, MD
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Patients who meet the indications for use for Triathlon® Total Knee System using VERASENSE™
- Subject must be diagnosed with one or more of the following conditions
- osteoarthritis
- rheumatoid or other inflammatory arthritis
- post-traumatic arthritis
- Subject is likely to be available for all study visits
- Subject is able and willing to sign the informed consent and follow study procedures
Exclusion Criteria:
- Prior Total Knee Arthroplasty
- Avascular Necrosis
- Any knee surgery other than meniscectomy (can be arthroscopic or open)
- Ligament insufficiencies, prior surgeries such as ACL or PCL reconstructions, posterolateral reconstructions, osteotomies, tibia plateau fractures
- Ipsilateral foot/ankle and hip arthritis
- Range of motion less than 90°, flexion contracture greater than 20°
- Subject has a mental condition that may interfere with the subject's ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the Subject cannot understand the informed consent process, global dementia, prior strokes that interfere with the Subject's cognitive abilities, senile dementia, and Alzheimer's Disease)
- Any subjects meeting any contraindication criteria as identified in the locally approved labeling for the device should be excluded from this study.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Sham-komparator: Group A TKA without VERASENSE
will consist of 250 consecutive patients who will undergo primary PCL-retaining or - sacrificing TKA without the use of VERASENSE to guide rotational alignment and balance.
|
TKA will be performed manually without the use of Verasense
|
Aktiv komparator: Group B TKA with VERASENSE
will consist of 250 consecutive patients who will undergo primary PCL-retaining or - sacrificing TKA with the use of VERASENSE to guide rotational alignment and balance.
|
VERASENSE replaces the standard tibial trial inserts and is embedded with microelectronics and sensors to provide surgeons with real-time knee kinetic data.
The data is wirelessly transmitted to a graphic display (VERASENSE Knee Application), allowing surgeons to quantify and assess soft tissue intercompartmental loads throughout the range of motion.
The VERASENSE sensor is not an investigational device.
OrthoSensor, Inc., received FDA 510K clearance in 2009.
The indication for use is a tool for adjustment of the femoral knee implant to reduce instability from flexion gap asymmetry.
The VERASENSE sensor is sterile and single patient use.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Knee Society Pain and Functional Scoring
Tidsramme: Changes from baseline at 24 months
|
Changes from baseline at 24 months
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Anterior Knee Pain Evaluation
Tidsramme: Changes from baseline at 24 months
|
Changes from baseline at 24 months
|
EQ5D
Tidsramme: Changes from baseline at 24 months
|
Changes from baseline at 24 months
|
Forgotten Joint Score
Tidsramme: Changes from baseline at 24 months
|
Changes from baseline at 24 months
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. april 2015
Primær færdiggørelse (Forventet)
1. december 2018
Studieafslutning (Forventet)
1. december 2018
Datoer for studieregistrering
Først indsendt
31. oktober 2014
Først indsendt, der opfyldte QC-kriterier
5. november 2014
Først opslået (Skøn)
10. november 2014
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
5. april 2017
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
4. april 2017
Sidst verificeret
1. april 2017
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 102
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med TKA without "Verasense"
-
Maisonneuve-Rosemont HospitalAktiv, ikke rekrutterendePersonlig tilfredshed | Ægte VarumCanada
-
The University of Tennessee, KnoxvilleSmith & Nephew, Inc.AfsluttetKnæ slidgigt | Total knæarthroplastik | KnæForenede Stater
-
Technische Universität DresdenAktiv, ikke rekrutterende
-
Ewha Womans UniversityAfsluttetGigt | Knæarthropati | Robotik
-
Hospices Civils de LyonAfsluttet
-
Chinese University of Hong KongIkke rekrutterer endnuKnæ slidgigt | Total knæarthroplastikHong Kong
-
Mahidol UniversityAfsluttet
-
Hospices Civils de LyonStryker NordicAfsluttetKnæarthroplastik, i alt | GanganalyseFrankrig
-
University of JenaUkendtTotal knæarthroplastik | Klinisk resultat
-
The University of Tennessee, KnoxvilleStryker OrthopaedicsAfsluttetKnæproteseForenede Stater